{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:20Z","timestamp":1761101000997},"reference-count":20,"publisher":"Wiley","issue":"5-6","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4223,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> The authors report the clinical and microbiological findings of a 6\u2010month follow\u2010up of nine AIDS patients affected with cryptococcosis. Among these, seven patients suffered from meningoencephalitis and two from disseminated infection. The antifungal therapy during acute illness included the administration of amphotericin B at doses of 0.6 mg kg<jats:sup>\u20101<\/jats:sup> day<jats:sup>\u20101<\/jats:sup> i.v. plus flucytosine at doses of 100 mg kg<jats:sup>\u20101<\/jats:sup> day<jats:sup>\u20101<\/jats:sup> i.v. during the first 15 days followed by itraconazole at doses of 400 mg day<jats:sup>\u20101<\/jats:sup> p.o. in the following 15 days. The maintenance treatment included itraconazole at doses of 200 mg day<jats:sup>\u20101<\/jats:sup> p.o. indefinitely. During the 6\u2010month follow\u2010up, one patient died of hepatic failure related to C virus (HCV) hepatitis reactivation and another patient died of polymicrobial pneumonia. In two patients, the presence of multiple nodular lesions in the cerebral computerized tomography (CT) scan, related to cryptococcal granulomas, was associated with the persistance of fungi in the cerebrospinal fluid. In three patients with meningoencephalitis the three\u2010drugs regimen was effective in eradicating the neurological infection, and relapses were not observed during the maintenance therapy with itraconazole during the 6\u2010month follow\u2010up. The two patients with haematogenous cryptococcosis did not relapse after the 6\u2010month follow\u2010up.<\/jats:p><jats:p><jats:bold>Zusammenfassung. <\/jats:bold> Die Studie informiert \u00fcber einen 6\u2010Monate\u2010Zeitraum einer noch nicht abgeschlossenen klinisch\u2010mikrobiologischen Beobachtung an neun Cryptococcose\u2010AIDS\u2010Patienten, sieben davon mit <jats:italic>Cryptococcus<\/jats:italic>\u2010Meningoenzephalitis und zwei mit disseminierter Cryptococcose. Alle Patienten wurden in der akuten Phase mit Amphotericin B (0.6 mg kg<jats:sup>\u20101<\/jats:sup> d<jats:sup>\u20101<\/jats:sup> i.v.) und Flucytosin (100 mg kg<jats:sup>\u20101<\/jats:sup> d<jats:sup>\u20101<\/jats:sup> i.v.) 15 Tage lang behandelt. Anschlie\u00dfend erhielten die Patienten Itraconazol (400 mg d<jats:sup>\u20101<\/jats:sup> per os) ebenfalls \u00fcber 15 Tage. Als Dauernachbehandlung wurde Itraconazol (200 mg d<jats:sup>\u20101<\/jats:sup>) auf unbestimmte Zeit verabreicht. W\u00e4hrend der 6\u2010monatigen Beobachtungszeit starb ein Patient an Leberversagen aufgrund der Reaktivierung einer HCV\u2010Hepatitis sowie ein weiterer an polymikrobieller Pneumonie. In zwei F\u00e4llen mit multiplen hypodensen L\u00e4sionen im Enzephalo\u2010CT, interpretiert als granulomat\u00f6se Lokalisation der Cryptococcose, war die Prognose negativ, weil nach 30 Therapietagen die Liquorkultur noch positiv war. Bei drei Patienten erwies sich das Therapieregime als wirksam. R\u00fcckfalle wurden in der 6\u2010monatigen Nachbeobachtungs\u2010periode nicht beobachtet, ebenso wenig bei den beiden Patienten mit disseminierter Cryptococcose.<\/jats:p>","DOI":"10.1111\/j.1439-0507.1997.tb00215.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T16:46:48Z","timestamp":1240591608000},"page":"203-207","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of a short\u2010term amphotericin B + flucytosine combination therapy followed by itraconazole mono therapy in acute and chronic AIDS\u2010associated cryptococcosis"],"prefix":"10.1111","volume":"40","author":[{"given":"A.","family":"Parisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Malfitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. F. A.","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Filice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-533"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260202"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.Supplement_2.S507"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199307000-00005"},{"key":"e_1_2_1_6_2","first-page":"139","article-title":"CT of intracranial cryptococcosis","volume":"11","author":"Popvich M. J.","year":"1990","journal-title":"Am. J. Nucl. Res."},{"key":"e_1_2_1_7_2","first-page":"283","article-title":"Intracranial cryptococcosis in immunocompromised patients: CT and RMI findings in 29 cases","volume":"12","author":"Tien R. D.","year":"1991","journal-title":"A.J.N.R."},{"issue":"2","key":"e_1_2_1_8_2","first-page":"56","article-title":"Therapy of candidosis and cryptococcosis in AIDS","volume":"37","author":"Just\u2010N\u00fcbling G.","year":"1994","journal-title":"Mycoses"},{"key":"e_1_2_1_9_2","first-page":"116","article-title":"Therapy of systemic mycoses in immunodeficiency","volume":"19","author":"Just\u2010N\u00fcbling G.","year":"1991","journal-title":"Immun. Infekt."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260202"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6618.339"},{"key":"e_1_2_1_12_2","volume-title":"Die antimykotische Chemotherapie opportunistischer Pilzinfektionen","author":"Polak\u2010Wyss A.","year":"1989"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/archinte.1989.00390100107024","article-title":"Itraconazole therapy for cryptococcal meningitis and cryptococcosis","volume":"149","author":"Denning D. W.","year":"1989","journal-title":"Arch. Inter. Med."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1995.tb00018.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909213211205"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-3-183"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-3-177"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70260-O"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1993.tb00755.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199202000-00007"},{"key":"e_1_2_1_21_2","first-page":"99","article-title":"Treatment of cryptococcal meningitis with a short course amphotericin B and flucytosine, followed by itraconazole","volume":"24","author":"Chotmongkol V.","year":"1993","journal-title":"S. Asian J. Trop. Med. Publ. Hlth."}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1997.tb00215.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1997.tb00215.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T18:11:24Z","timestamp":1693591884000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1997.tb00215.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":20,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1111\/j.1439-0507.1997.tb00215.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1997.tb00215.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}